review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1023822019 |
P356 | DOI | 10.1038/SJ.ONC.1204388 |
P698 | PubMed publication ID | 11402341 |
P2093 | author name string | Herrlich P | |
P2860 | cites work | Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis | Q77341367 |
Genetic dissection of glucocorticoid receptor function in mice | Q77485502 | ||
Anti-inflammatory actions of glucocorticoids: molecular mechanisms | Q77686959 | ||
A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR | Q24306431 | ||
Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor | Q24561876 | ||
The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain | Q24600925 | ||
CREB-binding protein in androgen receptor-mediated signaling | Q24685873 | ||
Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA | Q27651364 | ||
Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha | Q27730245 | ||
Molecular basis of agonism and antagonism in the oestrogen receptor | Q27746278 | ||
The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen | Q27766417 | ||
A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors | Q27860552 | ||
The nuclear receptor superfamily: the second decade | Q27860725 | ||
Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300 | Q28270979 | ||
A transcriptional co-repressor that interacts with nuclear hormone receptors | Q28289864 | ||
Functional interactions between Stat5 and the glucocorticoid receptor | Q28294034 | ||
Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP | Q28295041 | ||
Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin | Q28306447 | ||
Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation | Q28508582 | ||
Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection | Q28509078 | ||
Characterization of tumor necrosis factor-deficient mice | Q28512785 | ||
Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune re | Q28594116 | ||
The RXR heterodimers and orphan receptors | Q29547867 | ||
Steroid hormone receptors: many actors in search of a plot | Q29618397 | ||
Role of cytokines in rheumatoid arthritis | Q29620713 | ||
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase | Q30439814 | ||
Glucocorticoids antagonize AP-1 by inhibiting the Activation/phosphorylation of JNK without affecting its subcellular distribution | Q30918621 | ||
Effects of dexamethasone on mitogen-activated protein kinases in mouse macrophages: implications for the regulation of 85 kDa cytosolic phospholipase A(2). | Q31400445 | ||
Regulation of immune responses through inhibitory receptors | Q33652541 | ||
Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation | Q33708904 | ||
Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway | Q33797156 | ||
Integration of positive and negative growth signals during ras pathway activation in vivo | Q33840479 | ||
The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors | Q33881484 | ||
Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site | Q33923624 | ||
Mice with an increased glucocorticoid receptor gene dosage show enhanced resistance to stress and endotoxic shock | Q33966738 | ||
Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene. | Q34040999 | ||
Attenuation of tumor necrosis factor alpha gene transcription in macrophages by an autocrine factor | Q34170882 | ||
DNA binding of the glucocorticoid receptor is not essential for survival | Q34469789 | ||
Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell | Q35666145 | ||
Steroids and growth promoting factors in the regulation of expression of genes and gene networks | Q35834627 | ||
Unregulated expression of c-Jun or c-Fos proteins but not Jun D inhibits oestrogen receptor activity in human breast cancer derived cells | Q35928437 | ||
The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin | Q36326164 | ||
The PML-retinoic acid receptor alpha translocation converts the receptor from an inhibitor to a retinoic acid-dependent activator of transcription factor AP-1 | Q36587818 | ||
Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities | Q36743411 | ||
Aldosterone and dexamethasone stimulate calcineurin activity through a transcription-independent mechanism involving steroid receptor-associated heat shock proteins | Q37365030 | ||
Subfragments of the large terminal repeat cause glucocorticoid-responsive expression of mouse mammary tumor virus and of an adjacent gene | Q37614843 | ||
RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. | Q37695128 | ||
Influence of a steroid receptor DNA-binding domain on transcriptional regulatory functions | Q38301653 | ||
Positive and negative modulation of Jun action by thyroid hormone receptor at a unique AP1 site | Q38319606 | ||
Cell-specific bifunctional role of Jun oncogene family members on glucocorticoid receptor-dependent transcription. | Q38320510 | ||
Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone | Q38339139 | ||
I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor. | Q38343666 | ||
Different DNA elements can modulate the conformation of thyroid hormone receptor heterodimer and its transcriptional activity | Q38352956 | ||
All-trans-retinoic acid inhibits Jun N-terminal kinase by increasing dual-specificity phosphatase activity | Q39444829 | ||
Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo | Q39801075 | ||
The Glucocorticoid Receptor Synergizes with Jun Homodimers to Activate AP-1-regulated Promoters Lacking GR Binding Sites | Q40427637 | ||
Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway | Q40444275 | ||
The glucocorticoid receptor is required for stress erythropoiesis | Q40445916 | ||
The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation | Q40506162 | ||
Tumor necrosis factor: a pleiotropic cytokine and therapeutic target | Q40759728 | ||
Functional implications of brain corticosteroid receptor diversity. | Q40786578 | ||
Nuclear receptor/AP-1 interaction | Q40791352 | ||
A dual mechanism mediates repression of NF-kappaB activity by glucocorticoids | Q41056853 | ||
Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis | Q41283113 | ||
Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids | Q41283123 | ||
A new class of retinoids with selective inhibition of AP-1 inhibits proliferation | Q41429829 | ||
The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase | Q41455758 | ||
Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity | Q41523725 | ||
Molecules and mechanisms operating in septic shock: lessons from knockout mice | Q41546333 | ||
Glucocorticoid-mediated repression of intercellular adhesion molecule-1 expression in human monocytic and bronchial epithelial cell lines | Q41571869 | ||
Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element | Q41572923 | ||
Functional interference between the ubiquitous and constitutive octamer transcription factor 1 (OTF-1) and the glucocorticoid receptor by direct protein-protein interaction involving the homeo subdomain of OTF-1 | Q41595934 | ||
Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor | Q41721253 | ||
Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. | Q41721256 | ||
A nuclear factor for interleukin-6 expression (NF-IL6) and the glucocorticoid receptor synergistically activate transcription of the rat alpha 1-acid glycoprotein gene via direct protein-protein interaction | Q42127094 | ||
New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? | Q44607623 | ||
Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. | Q46040111 | ||
Determinants of target gene specificity for steroid/thyroid hormone receptors | Q46051437 | ||
A novel mechanism of action for v-ErbA: abrogation of the inactivation of transcription factor AP-1 by retinoic acid and thyroid hormone receptors. | Q46084143 | ||
Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene | Q46350140 | ||
Allosteric effects of DNA on transcriptional regulators | Q46483901 | ||
Intracellular receptors use a common mechanism to interpret signaling information at response elements | Q46908063 | ||
Cross-talk between steroids and NF-kappa B: what language? | Q47714581 | ||
Transcriptional cross-talk, the second mode of steroid hormone receptor action | Q47862003 | ||
Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation | Q48433814 | ||
Distinct domains of the RelA NF-kappaB subunit are required for negative cross-talk and direct interaction with the glucocorticoid receptor. | Q52192943 | ||
Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. | Q52221782 | ||
Disruption of Raf-1/heat shock protein 90 complex and Raf signaling by dexamethasone in mast cells. | Q52538241 | ||
Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer | Q53844461 | ||
Altered protein conformation on DNA binding by Fos and Jun. | Q54707375 | ||
Mutations in the glucocorticoid receptor DNA-binding domain mimic an allosteric effect of DNA 1 1Edited by P. E. Wright | Q57911215 | ||
Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management | Q60530953 | ||
Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression | Q62817899 | ||
Interleukin-1 stimulates and all-trans-retinoic acid inhibits collagenase gene expression through its 5' activator protein-1-binding site | Q68495174 | ||
Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum | Q70399995 | ||
Inhibition of mouse GATA-1 function by the glucocorticoid receptor: possible mechanism of steroid inhibition of erythroleukemia cell differentiation | Q70738010 | ||
Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis | Q71160284 | ||
Glucocorticoid receptor interaction with 14-3-3 and Raf-1, a proposed mechanism for cross-talk of two signal transduction pathways | Q73004180 | ||
Hormone-activated nuclear receptors inhibit the stimulation of the JNK and ERK signalling pathways in endothelial cells | Q73075184 | ||
Rapid signalling by androgen receptor in prostate cancer cells | Q73270723 | ||
P433 | issue | 19 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 2465-2475 | |
P577 | publication date | 2001-04-01 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | Cross-talk between glucocorticoid receptor and AP-1. | |
P478 | volume | 20 |
Q38349128 | A Silencer Element in the First Intron of the Glutamine Synthetase Gene Represses Induction by Glucocorticoids |
Q34115914 | A fully dissociated compound of plant origin for inflammatory gene repression |
Q35088185 | A novel aspartic proteinase-like gene expressed in stratified epithelia and squamous cell carcinoma of the skin. |
Q24559978 | A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-kappaB-regulated promoters |
Q30014831 | AP-1: a double-edged sword in tumorigenesis |
Q90414603 | Analysis of NFATc1 amplification in T cells for pharmacodynamic monitoring of tacrolimus in kidney transplant recipients |
Q35021922 | Anthrax lethal factor represses glucocorticoid and progesterone receptor activity |
Q87814853 | Anti-inflammatory effect of external use of escin on cutaneous inflammation: possible involvement of glucocorticoids receptor |
Q34717142 | Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile |
Q37368280 | Bacillus anthracis lethal toxin represses MMTV promoter activity through transcription factors |
Q44040266 | Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis. |
Q40630513 | Dexamethasone attenuates oxidation of extracellular matrix proteins by human monocytes |
Q51365307 | Dexamethasone facilitates lipid accumulation in chicken skeletal muscle. |
Q53824357 | Different chromatin and DNA sequence characteristics define glucocorticoid receptor binding sites that are blocked or not blocked by coregulator Hic-5. |
Q39970649 | Differential effects of triptolide and tetrandrine on activation of COX-2, NF-kappaB, and AP-1 and virus production in dengue virus-infected human lung cells. |
Q34538619 | Direct GR Binding Sites Potentiate Clusters of TF Binding across the Human Genome |
Q39157135 | Discovery of GW870086: a potent anti-inflammatory steroid with a unique pharmacological profile |
Q33691567 | Dissecting the Relation between a nuclear receptor and GATA: binding affinity studies of thyroid hormone receptor and GATA2 on TSHβ promoter |
Q38216934 | Does therapeutic intervention in atopic dermatitis normalize epidermal Notch deficiency? |
Q38301541 | Effect of T0901317 on hepatic proinflammatory gene expression in apoE-/- mice fed a high-fat/high-cholesterol diet |
Q90502094 | Effects of dietary energy level on appetite and central adenosine monophosphate-activated protein kinase (AMPK) in broilers |
Q40553683 | Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells |
Q24302908 | Enhancement of human ACAT1 gene expression to promote the macrophage-derived foam cell formation by dexamethasone |
Q48494798 | Epigenetic modulation of chronic anxiety and pain by histone deacetylation |
Q36486166 | Estradiol antagonism of glucocorticoid-induced GILZ expression in human uterine epithelial cells and murine uterus. |
Q35193155 | Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor |
Q44553010 | Experimental model of acute pancreatitis in Wistar rat: glucocorticoid treatment profile |
Q28586517 | Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response |
Q24313831 | From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response |
Q24300107 | Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells |
Q41954335 | Genomic determination of the glucocorticoid response reveals unexpected mechanisms of gene regulation |
Q39053368 | Genomic effects of glucocorticoids. |
Q36625248 | Glucocorticoid action and the development of selective glucocorticoid receptor ligands |
Q35884698 | Glucocorticoid efficacy in asthma: is improved tissue remodeling upstream of anti-inflammation |
Q40240328 | Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids. |
Q35585748 | Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells |
Q35831218 | Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. |
Q28578029 | Glucocorticoids activate TGF-beta induced PAI-1 and CTGF expression in rat hepatocytes |
Q92278625 | Hypoplastic acute myeloid leukemia in an elderly patient. A long-term partial remission with low-dose prednisone and G-CSF |
Q28155857 | Identification of glucocorticoid receptor domains involved in transrepression of transforming growth factor-beta action |
Q45245228 | Identification of molecules potentially involved in mediating the in vivo actions of the corticotropin-releasing hormone receptor 1 antagonist, NBI30775 (R121919). |
Q54708710 | Identification of novel AP-1 target genes in fibroblasts regulated during cutaneous wound healing. |
Q48732922 | Induction of tyrosine hydroxylase gene expression by glucocorticoids in the perinatal rat brain is age-dependent |
Q83305922 | Influence of hydrocortisone, prednisolone, and NO association on the evolution of acute pancreatitis |
Q38271452 | Inhibition of apoptosis in prostate cancer cells by androgens is mediated through downregulation of c-Jun N-terminal kinase activation |
Q26741279 | JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships |
Q37626844 | Leucine alleviates dexamethasone-induced suppression of muscle protein synthesis via synergy involvement of mTOR and AMPK pathways |
Q34130327 | Liganded thyroid hormone receptor inhibits phorbol 12-O-tetradecanoate-13-acetate-induced enhancer activity via firefly luciferase cDNA. |
Q42857270 | Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy |
Q37341018 | Mechanisms regulating the susceptibility of hematopoietic malignancies to glucocorticoid-induced apoptosis |
Q38765627 | MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response |
Q40658248 | Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis |
Q37825118 | Negative regulation by nuclear receptors: a plethora of mechanisms |
Q24794997 | Neural immune pathways and their connection to inflammatory diseases |
Q35759329 | New and emerging pharmacological targets for neuropathic pain |
Q34126046 | Nuclear hormone receptors in T lymphocytes |
Q37122891 | Nuclear receptors and inflammatory diseases |
Q44557361 | Pimecrolimus does not affect the differentiation, maturation and function of human monocyte-derived dendritic cells, in contrast to corticosteroids |
Q52544620 | Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer. |
Q28291197 | Principles for modulation of the nuclear receptor superfamily |
Q37300568 | Proteomic profiling of glucocorticoid-exposed myogenic cells: Time series assessment of protein translocation and transcription of inactive mRNAs |
Q28202771 | Reciprocal regulation of inflammation and lipid metabolism by liver X receptors |
Q37756178 | Regulation of drug-metabolizing cytochrome P450 enzymes by glucocorticoids. |
Q38293939 | Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor |
Q39444913 | Research resource: transcriptional response to glucocorticoids in childhood acute lymphoblastic leukemia |
Q38418725 | Retinoids stimulate periosteal bone resorption by enhancing the protein RANKL, a response inhibited by monomeric glucocorticoid receptor |
Q51350680 | Skeletal muscle fatty acids shift from oxidation to storage upon dexamethasone treatment in chickens. |
Q37658966 | Systematic dissection of genomic features determining transcription factor binding and enhancer function |
Q24299340 | TAF7 (TAFII55) plays a role in the transcription activation by c-Jun |
Q38326206 | TCDD induces c-jun expression via a novel Ah (dioxin) receptor-mediated p38-MAPK-dependent pathway. |
Q38430684 | Tethering not required: the glucocorticoid receptor binds directly to activator protein-1 recognition motifs to repress inflammatory genes. |
Q35118733 | The circadian clock: pacemaker and tumour suppressor |
Q42442957 | The glucocorticoid receptor as a potential target to reduce cocaine abuse. |
Q34480148 | The neuropeptide Y Y1 receptor knockdown modulates activator protein 1-involved feeding behavior in amphetamine-treated rats |
Q36174649 | The stimulus-dependent co-localization of serum- and glucocorticoid-regulated protein kinase (Sgk) and Erk/MAPK in mammary tumor cells involves the mutual interaction with the importin-alpha nuclear import protein |
Q44620845 | Transcription of stem cell factor (SCF) is potentiated by glucocorticoids and interleukin‐1β through concerted regulation of a GRE‐like and an NF‐κB response element |
Q30412500 | Transcriptional activity of c-Jun is critical for the suppression of AR function |
Q40727432 | Transrepression of AP-1 by nuclear receptors in Drosophila. |
Q28487685 | VBP15, a glucocorticoid analogue, is effective at reducing allergic lung inflammation in mice |
Q44219240 | VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis. |
Q35084895 | c-Fos-dependent induction of the small ras-related GTPase Rab11a in skin carcinogenesis |
Search more.